𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Salivary gland malignant neoplasms: Treatment and prognosis

✍ Scribed by Arne Borthne; Kjell Kjellevold; Olav Kaalhus; Halvor Vermund

Publisher
Elsevier Science
Year
1986
Tongue
English
Weight
958 KB
Volume
12
Category
Article
ISSN
0360-3016

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Recurrent malignant salivary gland neopl
Recurrent malignant salivary gland neoplasms
✍ M. A. Rodriguez-Bigas; Dr. K. Sako; M. S. Razack; D. P. Shedd; V. Y. Bakamjian; πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 373 KB

Recurrent salivary gland malignancies present difficult therapeutic decisions and poor prognosis in many instances, and treatment becomes of a palliative nature only. As many of the salivary gland malignancies we see are of the recurrent type, the following study was done to determine the efficacy o

Malignant neoplasms of the major salivar
Malignant neoplasms of the major salivary glands
✍ W. Thomas Lawrence; Walter Lawrence πŸ“‚ Article πŸ“… 1981 πŸ› John Wiley and Sons 🌐 English βš– 685 KB

## Abstract Between January 1, 1968 and December 31, 1978, 42 patients with malignant lesions involving the major salivary glands were seen at the Medical College of Virginia. A 60% 2‐year survival and a 42% 5‐year survival were noted. Histologic type was the major determinant of survival. Symptoms

Chemotherapy of advanced salivary gland
Chemotherapy of advanced salivary gland neoplasms
✍ Marshall R. Posner; Thomas J. Ervin; Ralph R. Weichselbaum; Richard L. Fabian; D πŸ“‚ Article πŸ“… 1982 πŸ› John Wiley and Sons 🌐 English βš– 340 KB
Radiation therapy in the treatment of ma
Radiation therapy in the treatment of malignant salivary gland tumors
✍ David Elkon; Martin Colman; Frank R. Hendrickson πŸ“‚ Article πŸ“… 1978 πŸ› John Wiley and Sons 🌐 English βš– 370 KB πŸ‘ 2 views

A retrospective analysis of 52 patients with malignant salivary gland tumors is reported. Seventeen patients received early postoperative radiation therapy and 16 (94%) were free of local or regional disease 2-14 years following initiation of therapy, although 14 were considered at high risk of deve